Louis Létinier
Synapse Biomedical (United States)(US)
Publications by Year
Research Areas
Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical Practices and Patient Outcomes, Biosimilars and Bioanalytical Methods, Substance Abuse Treatment and Outcomes, Coronary Interventions and Diagnostics
Most-Cited Works
- → Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)(2020)135 cited
- → Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data(2022)51 cited
- → Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study(2019)45 cited
- → Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions(2021)44 cited
- → Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID‐19 pandemic(2020)35 cited
- → Psychoactive substance use among students: A cross‐sectional analysis(2022)34 cited
- → Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database(2021)25 cited
- → Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies(2016)20 cited
- → Will the future of pharmacovigilance be more automated?(2023)17 cited
- → Emergency department admissions induced by drug–drug interactions in the elderly: A cross‐sectional study(2022)17 cited